Literature DB >> 10682169

New classification and diagnostic criteria for diabetes mellitus.

J R Gavin1.   

Abstract

There has been an explosive growth in knowledge about diabetes mellitus since the National Diabetes Data Group promulgated diagnostic criteria and a classification system in 1979 that was largely adopted by the World Health Organization. However, recent findings regarding the levels of glucose associated with development of retinopathy, and growing confusion caused by a system of classification of diabetes based largely on the treatment used have led to a new assessment of the diagnosis and classification of diabetes mellitus. Using new data from population-based studies, and placing emphasis on a pathophysiology-based system of classification, in 1997, the Expert Committee of the American Diabetes Association released its recommendations for the classification and diagnosis of diabetes. The major changes from the 1979 report include: (a) the preferred use of the terms "type 1" and "type 2" instead of "insulin-dependent" and "non-insulin-dependent" to designate the two major types of diabetes mellitus; (b) a simplification of the diagnostic test to two fasting plasma glucose (FPG) determinations; and (c) a lower cutoff for FPG (126 mg/dL) to diagnose diabetes (this level of FPG having been found equivalent to the 200-mg/dL value in the oral glucose tolerance test for diagnosis). These changes provide an easier and more reliable means of diagnosing persons at risk of complications of hyperglycemia. Even though the fasting criterion was lowered, the total number of persons who will be diagnosed with diabetes by exclusive reliance on FPG will actually be somewhat less than with the old criteria. Moreover, epidemiologic data support the recommendation that screening for diabetes should start at age 45 and be repeated every 3 years in persons without risk factors, and earlier and more often in those with risk factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10682169     DOI: 10.1016/s1098-3597(98)90014-x

Source DB:  PubMed          Journal:  Clin Cornerstone        ISSN: 1873-4480


  4 in total

Review 1.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

2.  Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection.

Authors:  Hesham M Elgouhari; Claudia O Zein; Ibrahim Hanouneh; Ariel E Feldstein; Nizar N Zein
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

3.  Lack of association between genetic variants in the 19q13.32 region and CHD risk in the Algerian population: a population-based nested case-control study.

Authors:  Houssam Boulenouar; Sarah Aicha Lardjam Hetraf; Hadjira Ouhaibi Djellouli; Djabaria Naima Meroufel; Faouzia Zemani Fodil; Imane Hammani-Medjaoui; Nadhira Saidi Mehtar; Leila Houti; Sounnia Mediene Benchekor
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

4.  The Impact of Admission Diagnosis on Recurrent or Frequent Hospitalizations in 3 Dementia Subtypes: A Hospital-Based Cohort in Taiwan with 4 Years Longitudinal Follow-Ups.

Authors:  Chiung-Chih Chang; Pin-Hsuan Lin; Ya-Ting Chang; Nai-Ching Chen; Chi-Wei Huang; Chun-Chung Lui; Shu-Hua Huang; Yen-Hsiang Chang; Chen-Chang Lee; Wei-An Lai
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.